EICHOR
● Active Not Recruiting
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Condition: Pulmonary Embolism · Sponsor: Boston Scientific Corporation
About this study
There are many available treatments for pulmonary embolism (PE), but the best treatment for this condition is not known. The HI-PEITHO study will compare two treatment options that are both available on the market for the treatment of PE. Patients will be randomized 1:1 to receive either blood thinners (anticoagulation) or blood thinners (anticoagulation) in combination with a device called the EkoSonicTM Endovascular device to dissolve blood clots. Patients will be followed for 12 months after randomization and have assessments while in the hospital as well as at 7 days, 30 days, 6 months and 12 months after randomization. The study will try to find out if one of these treatments is better than the other at reducing the risk of death and other serious problems.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (60)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Cedars - Sinai Medical Center | Los Angeles, California, United States | — |
| Christiana Hospital | Newark, Delaware, United States | — |
| Piedmont Hospital | Atlanta, Georgia, United States | — |
| Emory University Hospital | Atlanta, Georgia, United States | — |
| Augusta University | Augusta, Georgia, United States | — |
| Methodist Hospitals | Merrillville, Indiana, United States | — |
| Baptist Health East Louisville | Lousville, Kentucky, United States | — |
| University of Maryland School of Medicine | Baltimore, Maryland, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| University of Michigan Hospitals | Ann Arbor, Michigan, United States | — |
| Henry Ford Hospital | Detroit, Michigan, United States | — |
+ 48 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04790370